TriCan Health

What TriCan Health does

TriCan Health is a clinical trial navigation platform purpose-built for pancreatic cancer patients in the United States. The company operates a free, patient-facing web platform that walks patients through a short questionnaire about their specific pancreatic cancer subtype — including PDAC, PNET, Acinar Cell Carcinoma, IPMN, and Squamous Cell Carcinoma — and matches them to relevant US clinical trials drawn from a pool of 500+ actively recruiting pancreatic cancer studies. The platform also generates "Trial Snapshot" summaries that patients can save to personal albums and share with their medical team and family, addressing a navigation gap where 75% of cancer patients express interest in trials but only ~5% ultimately enroll.

The core technology is a question-based patient-to-trial matching workflow supported by a content-driven educational library ("Learn Articles") covering topics such as trial phases, targeted therapies, RAS mutations, early detection, and placebos. User accounts can be created via Google, Facebook, email, or phone, indicating a mobile-first, self-serve design. TriCan integrates Google Analytics for web traffic analytics and uses Facebook Insights for community engagement metrics, and is CCPA/CPRA- and GDPR-compliant, acting as data controller for personal and health information. The service is free for patients; revenue is implied to come from biopharma sponsors and CROs who benefit from improved patient recruitment, addressing the statistic that 40% of clinical trials fail to meet minimum enrollment.

TriCan is led by co-founders Kimya Harris, PhD (CEO, 30-year career in cancer research and drug development) and Mike Harris (COO, technology background), supported by an unusually credentialed advisory team: Scientific Advisor Lynn Matrisian, PhD (former PanCAN CSO, AACR President, NCI Director's Special Assistant, Vanderbilt Cancer Biology Chair); Medical Advisor Wendy Bernstein, MD (nearly 40 years of oncology practice); and Clinical Trials Advisor Megan Liles (25+ years across CRA to VP Clinical Delivery at a biotech-serving CRO). The company is incorporated as TriCan Health, LLC in Lexington, Massachusetts, and as of early 2026 its website is actively serving patients, with new educational articles published as recently as February 2026.

Name

TriCan Health

Legal name

TriCan Health, LLC

Website

https://tricanhealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

TriCan Health is a free, US-based web platform that matches pancreatic cancer patients to clinical trials through a questionnaire-based workflow, generates shareable trial summaries, and is positioned to monetize via biopharma sponsor and CRO patient recruitment services.

Ownership category

akta.pro rank

Product category

Clinical Trial Recruitment

NAICS

Computer Systems Design and Related Services (54151), Social Assistance (624)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro industry

PRIMARYHLALAKAH

Clinical Triage, Care Navigation & Routing Engines

Healthcare & Life Sciences/Telehealth Platforms/Telehealth Infrastructure & Enablement Platforms (video, scheduling, EHR integration)

SECONDARYHLACAGAA

Diagnostic & Triage Decision Support

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

Keywords

• Clinical trial matching
• Pancreatic cancer trials
• Patient trial navigation
• Oncology patient recruitment
• Biopharma enrollment services

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Biopharma Sponsor / CRO Recruitment Services: TriCan helps biotech and pharmaceutical sponsors enroll qualified patients into their clinical trials, addressing the problem that 40% of trials fail to meet minimum enrollment. The company collects patient information and shares it with clinical trial sites only when the patient expressly requests it. Revenue appears to come from facilitating patient-sponsor connections.
2. Free Patient Service: The platform is free for patients and caregivers. Patients pay no fee to search trials, receive matches, or share snapshots. The service is supported by the value it provides to sponsors and healthcare ecosystem partners.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Core offering

TriCan Health operates a free, web-based clinical trial navigation platform that helps pancreatic cancer patients in the United States discover, evaluate, and share relevant clinical trial options through a question-based matching flow. The platform provides Trial Snapshot summaries that patients can save and share with their medical team and family, and also serves biopharma sponsors and CROs seeking qualified patient enrollment for pancreatic cancer trials. The service bridges an information gap between patients seeking advanced treatments, doctors with limited research time, and sponsors struggling to enroll qualified patients.

Product overview

TriCan Health offers a unified clinical trial navigation platform designed specifically for pancreatic cancer patients in the United States. The core product is the Trial-Finder tool, which matches patients to clinical trials based on their cancer type. This is complemented by Trial Snapshot summaries that allow patients to browse, save, and share trial information with their care team. The platform also includes a Learn Articles section providing educational content about pancreatic cancer, targeted therapies, and clinical trial participation. The platform connects patients, doctors, and clinical trial sponsors in a three-way relationship to improve access to advanced treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Navigation Platform (Trial-Finder) A free, web-based clinical trial navigation platform that lets pancreatic cancer patients in the U.S. answer a few questions about their cancer type and condition to receive personalized clinical trial matches, save favorites, and share Trial Snapshot summaries with their medical team and family.
• Biopharma Sponsor / CRO Patient Recruitment Services A paid recruitment service through which TriCan Health connects biotech, pharmaceutical sponsors, and CROs with qualified pancreatic cancer patients seeking clinical trial participation, helping sponsors overcome the structural challenge that 40% of clinical trials fail to meet minimum patient enrollment.
• Learn Articles (Educational Content Library) An educational article library on the TriCan Health website covering pancreatic cancer basics, clinical trial phases, targeted therapies (including RAS-targeted therapies), early detection, and placebos in cancer trials, written for patients and caregivers to support informed clinical trial decisions.

Quantifiable outcome

• 75% of cancer patients want to learn more about clinical trials, yet only ~5% enroll — creating a massive gap the platform addresses
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Pancreatic Cancer Action Network (PanCAN)coreStrategic or Co-development PartnerPanCAN is the premier pancreatic cancer advocacy organization whose patient advocates recommend clinical trials be considered at every treatment decision. TriCan's About Us explicitly references PanCAN's guidance. Lynn Matrisian, PhD, TriCan's Scientific Advisor, previously served as Chief Science Officer at PanCAN, creating a direct link. This partnership provides credibility, patient referrals, and alignment with established clinical trial advocacy guidelines.
• Clinical Trial Sites / Clinical Trial SponsorscoreStrategic or Co-development PartnerTriCan Health shares patient information with clinical trial sites only when the patient expressly requests. Sponsors benefit from improved enrollment. The platform is positioned as bridging the gap between sponsors who need patients and patients who need trials. 40% of trials fail to meet enrollment minimums, creating a clear sponsor pain point TriCan addresses.
• Revolution Medicines (Daraxonrasib)minorGTM or Marketing PartnerRevolution Medicines' RAS inhibitor Daraxonrasib is featured prominently in TriCan's educational article on targeted therapies for pancreatic cancer. TriCan's trial finder would link patients to trials for this drug. This is a content/educational partnership where TriCan's educational content highlights specific drugs in active trials.
• Immuneering (Atebimetinib)minorGTM or Marketing PartnerImmuneering's Atebimetinib treatment is featured in TriCan's educational article on RAS-targeted therapies. The article references Immuneering's Phase 2 data showing 64% 12-month survival rate. TriCan serves as an educational and trial access channel for this drug's ongoing clinical trials.
• Bridge Bio (BBO-8520, BBO-11818)minorGTM or Marketing PartnerBridge Bio's RAS-targeted drug candidates BBO-8520 and BBO-11818 are mentioned in TriCan's educational content as emerging treatments in the pipeline. TriCan's educational articles serve as a patient awareness and trial recruitment channel for these drugs.
• Nikki Mitchell FoundationminorGTM or Marketing PartnerListed as an Additional Resource in TriCan's educational article. Provides comfort, relief, financial aid programs, and peer support to those affected by pancreatic cancer. TriCan cross-references this organization as part of its patient resource ecosystem.
• Imerman AngelsminorGTM or Marketing PartnerListed as an Additional Resource. Provides free, personalized one-on-one cancer support by matching patients to Mentor Angels with similar stories. Cross-referenced in TriCan's patient education ecosystem.
• SkyHopeminorGTM or Marketing PartnerListed as an Additional Resource. Provides free medical flights for patients to access trials and treatments located ~150-750 miles away. TriCan cross-references this as a complementary resource for patients whose matched trials require travel.
• Seena Magowitz FoundationminorGTM or Marketing PartnerListed as an Additional Resource and described as a great first point of contact for newly diagnosed patients, providing assistance finding top pancreatic cancer doctors and centers. TriCan's educational ecosystem includes this as a referral partner.
• Rolfe Pancreatic Cancer FoundationminorGTM or Marketing PartnerListed as an Additional Resource. Offers personal support, education, and connections for those facing pancreatic cancer, while funding early detection research. Part of TriCan's referral ecosystem.
• National Comprehensive Cancer Network (NCCN)minorGTM or Marketing PartnerReferenced in TriCan's educational content as providing treatment guidelines for both doctors and patients, including Guidelines for Patients available in multiple languages. NCCN guidelines are cited as authoritative source supporting TriCan's clinical trial messaging.
• American Association for Cancer Research (AACR)minorGTM or Marketing PartnerTriCan attended the AACR Pancreatic Cancer Conference and featured their research in two-part article series on early detection. AACR is cited as the source of scientific developments that TriCan translates into patient-accessible content.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Deep 6 AI: Deep 6 AI uses AI and NLP to mine EHR data for clinical trial matching, serving sponsors and sites. It is a direct peer because it competes for sponsor recruitment budgets with an alternative (EHR-data) approach to the patient-side approach TriCan takes.
• Clara Health: Clara Health is a patient-centric clinical trial navigation platform that helps patients find and enroll in trials. It is a direct peer because it offers the same patient-first trial discovery and matching experience as TriCan and competes for the same sponsor referral fees.
• Antidote (formerly TrialReach): Antidote is a digital clinical trial matching platform connecting patients to trials across multiple therapeutic areas. It is a direct peer because it offers the same patient-to-trial matching workflow as TriCan, monetizes via biopharma sponsors, and competes for the same sponsor recruitment budgets.
• Massive Bio: Massive Bio provides AI-driven clinical trial matching for oncology patients and recruits patients on behalf of sponsors. It is a direct peer because it targets the same oncology patient population and same sponsor recruitment pain point as TriCan, with an overlapping AI-enabled matching workflow.
• Power (Clinical Trial Platform): Power (formerly Clara Health's competitor brand) operates a patient-facing clinical trial discovery platform. It is a direct peer because it offers the same self-service trial matching workflow as TriCan with similar sponsor monetization.
• Carebox: Carebox provides AI-powered clinical trial matching for patients and recruitment services for sponsors. It is a direct peer because its matching engine and sponsor monetization model directly parallel TriCan's.

Broad incumbents

• ClinicalTrials.gov: ClinicalTrials.gov is the NIH-run registry of all clinical trials and is the default free search destination for patients seeking trials. It is a broad incumbent because it competes for patient mindshare and sponsor referrals but operates as a public utility rather than a commercial matching platform.
• IQVIA (E360 and Patient Engagement): IQVIA is the largest CRO and offers end-to-end clinical trial recruitment services including patient engagement platforms. It is a broad incumbent because it serves the same biopharma sponsors with a much broader portfolio of services, including direct trial recruitment that competes with TriCan's value proposition.

Others

• Pancreatic Cancer Action Network (PanCAN): PanCAN is the leading pancreatic cancer advocacy organization and an explicit partner/endorser of TriCan. It is an ecosystem participant rather than direct competitor because it provides patient services, education, and advocacy while referring patients to trial resources including TriCan.

Emerging players

• Mendel (Mendel AI): Mendel applies AI to clinical trial matching and patient cohort identification for sponsors. It is an emerging player because it primarily serves sponsors and CROs with structured patient cohort data rather than consumer-facing trial discovery, giving partial overlap with TriCan.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php?id=100091515043735

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TriCan Health